|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.00 SEK | -1.72% |
|
+7.53% | -28.83% |
| 12-01 | Merck showcases data for Alzheimer's disease candidates MK-2214 and MK-1167 at CTAD 2025 | RE |
| 11-10 | CTT's Banco CTT prices senior debt issuance of 45 mln euros | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 207M | 154M | 244M | 311M | 302M | |||||
Other Revenues, Total | -100K | - | - | - | - | |||||
Total Revenues | 207M | 154M | 244M | 311M | 302M | |||||
Cost of Goods Sold, Total | 57.5M | 35.8M | 46.6M | 63.2M | 60.6M | |||||
Gross Profit | 149M | 118M | 197M | 248M | 242M | |||||
Selling General & Admin Expenses, Total | 109M | 97.1M | 104M | 116M | 129M | |||||
Depreciation & Amortization - (IS) | 6.8M | 7M | 7.9M | 9.3M | 7.5M | |||||
Other Operating Expenses | -700K | -200K | -500K | 1.1M | -2.9M | |||||
Other Operating Expenses, Total | 115M | 104M | 112M | 126M | 134M | |||||
Operating Income | 34.4M | 14.5M | 85.5M | 121M | 108M | |||||
Interest Expense, Total | -1.2M | -8.9M | -9M | -3.4M | -3.2M | |||||
Interest And Investment Income | 2.4M | - | 1M | 2.5M | 2.7M | |||||
Net Interest Expenses | 1.2M | -8.9M | -8M | -900K | -500K | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Currency Exchange Gains (Loss) | 100K | 7.5M | 6.4M | 200K | 300K | |||||
Other Non Operating Income (Expenses) | - | - | -100K | 0 | 200K | |||||
EBT, Excl. Unusual Items | 35.7M | 13.1M | 83.8M | 120M | 108M | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | - | -4.3M | - | - | - | |||||
Other Unusual Items | 3.9M | 9.1M | - | - | - | |||||
EBT, Incl. Unusual Items | 39.6M | 17.9M | 83.8M | 120M | 108M | |||||
Income Tax Expense | 8.5M | 3.7M | 17.5M | 25M | 22.2M | |||||
Earnings From Continuing Operations | 31.1M | 14.2M | 66.3M | 95.5M | 85.5M | |||||
Net Income to Company | 31.1M | 14.2M | 66.3M | 95.5M | 85.5M | |||||
Net Income - (IS) | 31.1M | 14.2M | 66.3M | 95.5M | 85.5M | |||||
Net Income to Common Incl Extra Items | 31.1M | 14.2M | 66.3M | 95.5M | 85.5M | |||||
Net Income to Common Excl. Extra Items | 31.1M | 14.2M | 66.3M | 95.5M | 85.5M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.48 | 1.13 | 5.29 | 7.62 | 6.82 | |||||
Basic EPS - Continuing Operations | 2.48 | 1.13 | 5.29 | 7.62 | 6.82 | |||||
Basic Weighted Average Shares Outstanding | 12.53M | 12.53M | 12.53M | 12.53M | 12.53M | |||||
Net EPS - Diluted | 2.48 | 1.13 | 5.29 | 7.62 | 6.82 | |||||
Diluted EPS - Continuing Operations | 2.48 | 1.13 | 5.29 | 7.62 | 6.82 | |||||
Diluted Weighted Average Shares Outstanding | 12.53M | 12.53M | 12.53M | 12.53M | 12.53M | |||||
Normalized Basic EPS | 1.78 | 0.65 | 4.18 | 6.01 | 5.37 | |||||
Normalized Diluted EPS | 1.78 | 0.65 | 4.18 | 6.01 | 5.37 | |||||
Dividend Per Share | 1.74 | 0.79 | 4.05 | 5.35 | 5.35 | |||||
Payout Ratio | 163.02 | 153.52 | 14.93 | 53.09 | 127.49 | |||||
Supplemental Items | ||||||||||
EBITDA | 40.1M | 20.5M | 91.5M | 127M | 113M | |||||
EBITA | 35.3M | 14.8M | 85.8M | 122M | 108M | |||||
EBIT | 34.4M | 14.5M | 85.5M | 121M | 108M | |||||
EBITDAR | 46.8M | 26.7M | 98.1M | 135M | 121M | |||||
Total Revenues (As Reported) | 233M | 176M | 263M | 312M | 319M | |||||
Effective Tax Rate - (Ratio) | 21.46 | 20.67 | 20.88 | 20.75 | 20.61 | |||||
Total Current Taxes | 8.5M | 3.7M | 17.5M | 25M | 22.2M | |||||
Total Deferred Taxes | - | - | - | - | - | |||||
Normalized Net Income | 22.31M | 8.19M | 52.38M | 75.31M | 67.31M | |||||
Non-Cash Pension Expense | - | - | 200K | 200K | - | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 2.2M | 4.8M | 4.2M | 5.5M | 5.6M | |||||
Net Rental Expense, Total | 6.7M | 6.2M | 6.6M | 7.5M | 7.6M | |||||
Imputed Operating Lease Interest Expense | 1.85M | 8.09M | 8.07M | 4.67M | 4.53M | |||||
Imputed Operating Lease Depreciation | 4.85M | -1.89M | -1.47M | 2.83M | 3.07M |
- Stock Market
- Equities
- CTT Stock
- Financials CTT Systems AB
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















